Posted by Michael Wonder on 30 Jan 2022
Medicines regulator pilot probes pharma delays in market launches
25 January 2022 - The European Medicines Agency wants to get a better understanding of drug companies’ commercial intentions and why.
The EMA is carrying out a pilot to better understand companies’ launch plans for new products across the bloc.
This voluntary survey is designed to find out when and where companies intend to bring their products to market first — and why — gathering evidence on the reasons for delays in some countries.
